We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $32.4B
1-Year Est. Return 58.5%
This Fund
S&P 500
This Quarter Est. Return
+23.19%
1 Year Est. Return
+58.5%
3 Year Est. Return
+155.34%
5 Year Est. Return
+222.91%
10 Year Est. Return
AUM
$32.4B
AUM Growth
+$5.91B
Cap. Flow
+$1.91B
Cap. Flow %
5.91%
Top 10 Hldgs %
17.19%
Holding
1,187
New
164
Increased
545
Reduced
215
Closed
176

Sector Composition

Rank Sector Weight
1 Healthcare 25.1%
2 Technology 24.74%
3 Financials 10.96%
4 Consumer Discretionary 9.79%
5 Industrials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UI icon
1001
Ubiquiti
UI
$33.5B
$239K ﹤0.01%
447
-207
-32% -$156K
AVTX icon
1002
Avalo Therapeutics
AVTX
$905M
$232K ﹤0.01%
+12,544
New +$198K
FTAI icon
1003
FTAI Aviation
FTAI
$18.9B
$230K ﹤0.01%
849
-313
-27% -$78.7K
ARM icon
1004
Arm
ARM
$272B
$212K ﹤0.01%
597
-743
-55% -$198K
VERX icon
1005
Vertex
VERX
$1.99B
$203K ﹤0.01%
+17,666
New +$221K
DV icon
1006
DoubleVerify
DV
$2.08B
$185K ﹤0.01%
+17,093
New +$176K
PTN
1007
Palatin Technologies
PTN
$21.3M
$121K ﹤0.01%
+11,244
New +$185K
CNTX icon
1008
Context Therapeutics
CNTX
$33.3M
$43.2K ﹤0.01%
77,933
-172,155
-69% -$349K
DAVA icon
1009
Endava
DAVA
$152M
$43K ﹤0.01%
15,205
-8,407
-36% -$31K
AA icon
1010
Alcoa
AA
$12.7B
-80,814
Closed -$5.36M
ACAD icon
1011
Acadia Pharmaceuticals
ACAD
$4.79B
-676,401
Closed -$15.1M
ACET icon
1012
Adicet Bio
ACET
$88.9M
-313,124
Closed -$2.13M
ACHC icon
1013
Acadia Healthcare
ACHC
$2.66B
-390,830
Closed -$9.14M
ACI icon
1014
Albertsons Companies
ACI
$5.79B
-3,522,398
Closed -$60M
ACLX
1015
DELISTED
Arcellx
ACLX
-123,750
Closed -$14.2M
ACM icon
1016
Aecom
ACM
$8.2B
-5,160
Closed -$438K
AFL icon
1017
Aflac
AFL
$57.4B
-81,801
Closed -$8.97M
AGIO icon
1018
Agios Pharmaceuticals
AGIO
$2.03B
-74,423
Closed -$2.52M
AIP icon
1019
Arteris
AIP
$1.13B
-79,263
Closed -$1.3M
AL
1020
DELISTED
Air Lease Corp
AL
-408,500
Closed -$26.5M
ALC icon
1021
Alcon
ALC
$32B
-232,129
Closed -$17.5M
ALL icon
1022
Allstate
ALL
$63.7B
-3,775
Closed -$783K
AMBA icon
1023
Ambarella
AMBA
$2.95B
-349,479
Closed -$18M
AMG icon
1024
Affiliated Managers Group
AMG
$9.14B
-145,879
Closed -$40.4M
APLS
1025
DELISTED
Apellis Pharmaceuticals
APLS
-976,175
Closed -$39.3M

Similar funds

Woodline Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Woodline Partners held 1,187 positions worth $32.4B, up 22% from $26.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.91B of net new capital in Q2 2026, opening 164 new positions and adding to 545 existing holdings. Its largest new stake was SpaceX: 508,235 shares worth $86.8M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Texas Instruments, an estimated $215M trimmed.

  • Woodline Partners's largest Q2 2026 buy was SpaceX: 508,235 shares worth $86.8M.
  • Woodline Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $261M increase.
  • Woodline Partners's biggest Q2 2026 reduction was Texas Instruments, cutting an estimated $215M.
  • Woodline Partners fully exited SSR Mining in Q2 2026, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 17% of its $32.4B portfolio in Q2 2026.
  • Woodline Partners opened 164 new positions and closed 176 in Q2 2026.
  • Woodline Partners's portfolio value rose 22% quarter-over-quarter to $32.4B.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.